Medtronic plc (MDT) Financials & Stock Analysis

Medtronic plc

NYSE: MDT · USD

Revenue

USD millions

$9,756M

Medtronic plc Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
Period	Revenue
FY 2015 Q3	$0M; Change unavailable vs FY 2015 Q2
FY 2015 Q4	$7,304M; Change unavailable vs FY 2015 Q3
FY 2016 Q1	$7,274M; −0.4% vs FY 2015 Q4
FY 2016 Q2	$7,058M; −3.0% vs FY 2016 Q1
FY 2016 Q3	$6,934M; −1.8% vs FY 2016 Q2
FY 2016 Q4	$7,567M; +9.1% vs FY 2016 Q3
FY 2017 Q1	$7,166M; −5.3% vs FY 2016 Q4
FY 2017 Q2	$7,345M; +2.5% vs FY 2017 Q1
FY 2017 Q3	$7,283M; −0.8% vs FY 2017 Q2
FY 2017 Q4	$7,916M; +8.7% vs FY 2017 Q3
FY 2018 Q1	$7,390M; −6.6% vs FY 2017 Q4
FY 2018 Q2	$7,050M; −4.6% vs FY 2018 Q1
FY 2018 Q3	$7,369M; +4.5% vs FY 2018 Q2
FY 2018 Q4	$8,144M; +10.5% vs FY 2018 Q3
FY 2019 Q1	$7,384M; −9.3% vs FY 2018 Q4
FY 2019 Q2	$7,481M; +1.3% vs FY 2019 Q1
FY 2019 Q3	$7,546M; +0.9% vs FY 2019 Q2
FY 2019 Q4	$8,146M; +8.0% vs FY 2019 Q3
FY 2020 Q1	$7,493M; −8.0% vs FY 2019 Q4
FY 2020 Q2	$7,706M; +2.8% vs FY 2020 Q1
FY 2020 Q3	$7,717M; +0.1% vs FY 2020 Q2
FY 2020 Q4	$5,998M; −22.3% vs FY 2020 Q3
FY 2021 Q1	$6,507M; +8.5% vs FY 2020 Q4
FY 2021 Q2	$7,647M; +17.5% vs FY 2021 Q1
FY 2021 Q3	$7,775M; +1.7% vs FY 2021 Q2
FY 2021 Q4	$8,188M; +5.3% vs FY 2021 Q3
FY 2022 Q1	$7,987M; −2.5% vs FY 2021 Q4
FY 2022 Q2	$7,847M; −1.8% vs FY 2022 Q1
FY 2022 Q3	$7,763M; −1.1% vs FY 2022 Q2
FY 2022 Q4	$8,089M; +4.2% vs FY 2022 Q3
FY 2023 Q1	$7,371M; −8.9% vs FY 2022 Q4
FY 2023 Q2	$7,585M; +2.9% vs FY 2023 Q1
FY 2023 Q3	$7,727M; +1.9% vs FY 2023 Q2
FY 2023 Q4	$8,545M; +10.6% vs FY 2023 Q3
FY 2024 Q1	$7,702M; −9.9% vs FY 2023 Q4
FY 2024 Q2	$7,984M; +3.7% vs FY 2024 Q1
FY 2024 Q3	$8,089M; +1.3% vs FY 2024 Q2
FY 2024 Q4	$8,589M; +6.2% vs FY 2024 Q3
FY 2025 Q1	$7,915M; −7.8% vs FY 2024 Q4
FY 2025 Q2	$8,403M; +6.2% vs FY 2025 Q1
FY 2025 Q3	$8,292M; −1.3% vs FY 2025 Q2
FY 2025 Q4	$8,927M; +7.7% vs FY 2025 Q3
FY 2026 Q1	$8,578M; −3.9% vs FY 2025 Q4
FY 2026 Q2	$8,961M; +4.5% vs FY 2026 Q1
FY 2026 Q3	$9,017M; +0.6% vs FY 2026 Q2
FY 2026 Q4	$9,807M; +8.8% vs FY 2026 Q3
FY 2027 Q1	$9,756M; −0.5% vs FY 2026 Q4

Free cash flow

USD millions

$1,290M

Medtronic plc Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
Period	Free cash flow
FY 2015 Q3	$1,661M; Change unavailable vs FY 2015 Q2
FY 2015 Q4	$1,657M; −0.2% vs FY 2015 Q3
FY 2016 Q1	$592M; −64.3% vs FY 2015 Q4
FY 2016 Q2	$1,057M; +78.5% vs FY 2016 Q1
FY 2016 Q3	$1,550M; +46.6% vs FY 2016 Q2
FY 2016 Q4	$973M; −37.2% vs FY 2016 Q3
FY 2017 Q1	$1,220M; +25.4% vs FY 2016 Q4
FY 2017 Q2	$1,204M; −1.3% vs FY 2017 Q1
FY 2017 Q3	$1,759M; +46.1% vs FY 2017 Q2
FY 2017 Q4	$1,443M; −18.0% vs FY 2017 Q3
FY 2018 Q1	$459M; −68.2% vs FY 2017 Q4
FY 2018 Q2	$661M; +44.0% vs FY 2018 Q1
FY 2018 Q3	$1,750M; +164.8% vs FY 2018 Q2
FY 2018 Q4	$746M; −57.4% vs FY 2018 Q3
FY 2019 Q1	$1,411M; +89.1% vs FY 2018 Q4
FY 2019 Q2	$957M; −32.2% vs FY 2019 Q1
FY 2019 Q3	$1,753M; +83.2% vs FY 2019 Q2
FY 2019 Q4	$1,752M; −0.1% vs FY 2019 Q3
FY 2020 Q1	$1,209M; −31.0% vs FY 2019 Q4
FY 2020 Q2	$1,584M; +31.0% vs FY 2020 Q1
FY 2020 Q3	$2,114M; +33.5% vs FY 2020 Q2
FY 2020 Q4	$1,114M; −47.3% vs FY 2020 Q3
FY 2021 Q1	$-56M; −105.0% vs FY 2020 Q4
FY 2021 Q2	$1,580M; +2921.4% vs FY 2021 Q1
FY 2021 Q3	$1,993M; +26.1% vs FY 2021 Q2
FY 2021 Q4	$1,368M; −31.4% vs FY 2021 Q3
FY 2022 Q1	$914M; −33.2% vs FY 2021 Q4
FY 2022 Q2	$1,498M; +63.9% vs FY 2022 Q1
FY 2022 Q3	$1,898M; +26.7% vs FY 2022 Q2
FY 2022 Q4	$1,668M; −12.1% vs FY 2022 Q3
FY 2023 Q1	$657M; −60.6% vs FY 2022 Q4
FY 2023 Q2	$599M; −8.8% vs FY 2023 Q1
FY 2023 Q3	$1,242M; +107.3% vs FY 2023 Q2
FY 2023 Q4	$2,082M; +67.6% vs FY 2023 Q3
FY 2024 Q1	$521M; −75.0% vs FY 2023 Q4
FY 2024 Q2	$200M; −61.6% vs FY 2024 Q1
FY 2024 Q3	$2,128M; +964.0% vs FY 2024 Q2
FY 2024 Q4	$2,351M; +10.5% vs FY 2024 Q3
FY 2025 Q1	$466M; −80.2% vs FY 2024 Q4
FY 2025 Q2	$554M; +18.9% vs FY 2025 Q1
FY 2025 Q3	$2,096M; +278.3% vs FY 2025 Q2
FY 2025 Q4	$2,069M; −1.3% vs FY 2025 Q3
FY 2026 Q1	$584M; −71.8% vs FY 2025 Q4
FY 2026 Q2	$457M; −21.7% vs FY 2026 Q1
FY 2026 Q3	$2,300M; +403.3% vs FY 2026 Q2
FY 2026 Q4	$2,085M; −9.3% vs FY 2026 Q3
FY 2027 Q1	$1,290M; −38.1% vs FY 2026 Q4

Net margin

15.07%

Medtronic plc Net margin. Reported fiscal history.
Fiscal period	%
FY 2015 Q3	—
FY 2015 Q4	-0.01%
FY 2016 Q1	11.27%
FY 2016 Q2	7.37%
FY 2016 Q3	15.79%
FY 2016 Q4	14.59%
FY 2017 Q1	12.96%
FY 2017 Q2	15.18%
FY 2017 Q3	11.27%
FY 2017 Q4	14.69%
FY 2018 Q1	13.75%
FY 2018 Q2	28.61%
FY 2018 Q3	-18.85%
FY 2018 Q4	17.93%
FY 2019 Q1	14.56%
FY 2019 Q2	14.9%
FY 2019 Q3	16.82%
FY 2019 Q4	14.39%
FY 2020 Q1	11.53%
FY 2020 Q2	17.7%
FY 2020 Q3	24.82%
FY 2020 Q4	10.77%
FY 2021 Q1	7.48%
FY 2021 Q2	6.39%
FY 2021 Q3	16.33%
FY 2021 Q4	16.61%
FY 2022 Q1	9.55%
FY 2022 Q2	16.71%
FY 2022 Q3	19.06%
FY 2022 Q4	18.36%
FY 2023 Q1	12.6%
FY 2023 Q2	5.63%
FY 2023 Q3	15.81%
FY 2023 Q4	13.8%
FY 2024 Q1	10.27%
FY 2024 Q2	11.39%
FY 2024 Q3	16.34%
FY 2024 Q4	7.61%
FY 2025 Q1	13.16%
FY 2025 Q2	15.11%
FY 2025 Q3	15.61%
FY 2025 Q4	11.83%
FY 2026 Q1	12.12%
FY 2026 Q2	15.33%
FY 2026 Q3	12.68%
FY 2026 Q4	12.68%
FY 2027 Q1	15.07%

P/E

× · TTM · Daily

21.78×

Medtronic plc P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date	× · TTM · Daily	Financials through
2015-06-30	30.72×	2015-04-24
2015-07-31	32.5×	2015-04-24
2015-08-31	29.97×	2015-04-24
2015-09-30	27.75×	2015-04-24
2015-10-30	30.65×	2015-04-24
2015-11-30	31.23×	2015-04-24
2015-12-31	31.89×	2015-04-24
2016-01-29	31.47×	2015-04-24
2016-02-29	32.08×	2015-04-24
2016-03-31	40.39×	2015-04-24
2016-04-29	42.62×	2015-04-24
2016-05-31	43.34×	2015-04-24
2016-06-30	34.72×	2016-04-29
2016-07-29	35.07×	2016-04-29
2016-08-31	34.83×	2016-04-29
2016-09-30	33.33×	2016-07-29
2016-10-31	31.64×	2016-07-29
2016-11-30	28.16×	2016-07-29
2016-12-30	23.38×	2016-10-28
2017-01-31	24.95×	2016-10-28
2017-02-28	26.55×	2016-10-28
2017-03-31	28.07×	2017-01-27
2017-04-28	28.95×	2017-01-27
2017-05-31	29.37×	2017-01-27
2017-06-30	30.44×	2017-04-28
2017-07-31	28.8×	2017-04-28
2017-08-31	27.65×	2017-04-28
2017-09-29	26×	2017-07-28
2017-10-31	26.92×	2017-07-28
2017-11-30	27.46×	2017-07-28
2017-12-29	21.98×	2017-10-27
2018-01-31	23.38×	2017-10-27
2018-02-28	21.75×	2017-10-27
2018-03-29	38.7×	2018-01-26
2018-04-30	38.65×	2018-01-26
2018-05-31	41.64×	2018-01-26
2018-06-29	37.68×	2018-04-27
2018-07-31	39.71×	2018-04-27
2018-08-31	42.43×	2018-04-27
2018-09-28	42.46×	2018-07-27
2018-10-31	38.77×	2018-07-27
2018-11-30	58.7×	2018-10-26
2018-12-31	54.75×	2018-10-26
2019-01-31	53.2×	2018-10-26
2019-02-28	54.47×	2018-10-26
2019-03-29	25.05×	2019-01-25
2019-04-30	24.42×	2019-01-25
2019-05-31	25.46×	2019-01-25
2019-06-28	28.42×	2019-04-26
2019-07-31	29.75×	2019-04-26
2019-08-30	31.49×	2019-04-26
2019-09-30	33.22×	2019-07-26
2019-10-31	33.31×	2019-07-26
2019-11-29	34.07×	2019-07-26
2019-12-31	32.84×	2019-10-25
2020-01-31	33.41×	2019-10-25
2020-02-28	29.14×	2019-10-25
2020-03-31	22.93×	2020-01-24
2020-04-30	24.83×	2020-01-24
2020-05-29	25.07×	2020-01-24
2020-06-30	25.84×	2020-04-24
2020-07-31	27.19×	2020-04-24
2020-08-31	30.29×	2020-04-24
2020-09-30	31.8×	2020-07-31
2020-10-30	30.77×	2020-07-31
2020-11-30	34.79×	2020-07-31
2020-12-31	44.78×	2020-10-30
2021-01-29	42.56×	2020-10-30
2021-02-26	44.71×	2020-10-30
2021-03-31	55.39×	2021-01-29
2021-04-30	61.39×	2021-01-29
2021-05-28	59.36×	2021-01-29
2021-06-30	46.75×	2021-04-30
2021-07-30	49.45×	2021-04-30
2021-08-31	50.27×	2021-04-30
2021-09-30	43.8×	2021-07-30
2021-10-29	41.88×	2021-07-30
2021-11-30	37.28×	2021-07-30
2021-12-31	29.81×	2021-10-29
2022-01-31	29.82×	2021-10-29
2022-02-28	30.25×	2021-10-29
2022-03-31	30.49×	2022-01-28
2022-04-29	28.68×	2022-01-28
2022-05-31	27.52×	2022-01-28
2022-06-30	23.94×	2022-04-29
2022-07-29	24.68×	2022-04-29
2022-08-31	23.45×	2022-04-29
2022-09-30	20.7×	2022-07-29
2022-10-31	22.39×	2022-07-29
2022-11-30	20.26×	2022-07-29
2022-12-30	23.96×	2022-10-28
2023-01-31	25.8×	2022-10-28
2023-02-28	25.52×	2022-10-28
2023-03-31	26.43×	2023-01-27
2023-04-28	29.82×	2023-01-27
2023-05-31	27.13×	2023-01-27
2023-06-30	28.88×	2023-01-27
2023-07-31	28.77×	2023-01-27
2023-08-31	26.72×	2023-01-27
2023-09-29	28.88×	2023-07-28
2023-10-31	26.01×	2023-07-28
2023-11-30	29.22×	2023-07-28
2023-12-29	26.75×	2023-10-27
2024-01-31	28.43×	2023-10-27
2024-02-29	26.42×	2024-01-26
2024-03-28	27.63×	2024-01-26
2024-04-30	25.44×	2024-01-26
2024-05-31	25.79×	2024-01-26
2024-06-28	28.34×	2024-04-26
2024-07-31	28.92×	2024-04-26
2024-08-30	31.89×	2024-04-26
2024-09-30	32.42×	2024-04-26
2024-10-31	32.14×	2024-04-26
2024-11-29	31.16×	2024-04-26
2024-12-31	28.76×	2024-04-26
2025-01-31	32.7×	2024-04-26
2025-02-28	33.13×	2024-04-26
2025-03-31	32.36×	2024-04-26
2025-04-30	30.52×	2024-04-26
2025-05-30	29.88×	2024-04-26
2025-06-30	24.08×	2025-04-25
2025-07-31	24.93×	2025-04-25
2025-08-29	25.64×	2025-04-25
2025-09-30	26.31×	2025-04-25
2025-10-31	25.05×	2025-04-25
2025-11-28	29.1×	2025-04-25
2025-12-31	26.53×	2025-04-25
2026-01-30	28.44×	2025-04-25
2026-02-27	27.3×	2026-01-23
2026-03-31	24.22×	2026-01-23
2026-04-30	22.63×	2026-01-23
2026-05-29	20.63×	2026-01-23
2026-06-30	20.98×	2026-04-24
2026-07-31	22.9×	2026-04-24
2026-08-31	24.32×	2026-04-24
2026-09-25	21.78×	2026-07-31

ROIC

% · Annual / TTM

7.09%

Medtronic plc ROIC. Reported fiscal history.
Fiscal period	% · Annual / TTM
FY 2015 Q3	—
FY 2015 Q4	—
FY 2016 Q1	—
FY 2016 Q2	—
FY 2016 Q3	—
FY 2016 Q4	5.23%
FY 2017 Q1	5.36%
FY 2017 Q2	6.14%
FY 2017 Q3	5.89%
FY 2017 Q4	5.85%
FY 2018 Q1	5.92%
FY 2018 Q2	7.37%
FY 2018 Q3	4.34%
FY 2018 Q4	4.78%
FY 2019 Q1	4.8%
FY 2019 Q2	3.61%
FY 2019 Q3	7.61%
FY 2019 Q4	7.79%
FY 2020 Q1	8.13%
FY 2020 Q2	8.42%
FY 2020 Q3	—
FY 2020 Q4	—
FY 2021 Q1	—
FY 2021 Q2	—
FY 2021 Q3	—
FY 2021 Q4	5.73%
FY 2022 Q1	5.98%
FY 2022 Q2	6.6%
FY 2022 Q3	6.8%
FY 2022 Q4	7.15%
FY 2023 Q1	7.39%
FY 2023 Q2	6.08%
FY 2023 Q3	5.64%
FY 2023 Q4	5.24%
FY 2024 Q1	5%
FY 2024 Q2	5.66%
FY 2024 Q3	5.74%
FY 2024 Q4	5.3%
FY 2025 Q1	5.55%
FY 2025 Q2	6%
FY 2025 Q3	6.08%
FY 2025 Q4	6.68%
FY 2026 Q1	6.75%
FY 2026 Q2	6.86%
FY 2026 Q3	6.66%
FY 2026 Q4	6.77%
FY 2027 Q1	7.09%

Capital allocation

% of tracked cash uses

$2,853M

Medtronic plc capital allocation. Quarterly values. Missing values are unavailable.
Period	Capex	Acquisitions	Buybacks	Dividends	Debt repayments	Tracked uses
FY 2015 Q3	23.82% · $106M	7.42% · $33M	0% · $0M	67.42% · $300M	1.35% · $6M	100% · $445M
FY 2015 Q4	1.54% · $255M	86.41% · $14,273M	1.82% · $300M	2.63% · $435M	7.6% · $1,255M	100% · $16,518M
FY 2016 Q1	8.31% · $224M	6.64% · $179M	27.83% · $750M	19.96% · $538M	37.25% · $1,004M	100% · $2,695M
FY 2016 Q2	7.68% · $222M	28.29% · $818M	24.56% · $710M	18.57% · $537M	20.89% · $604M	100% · $2,891M
FY 2016 Q3	15.16% · $247M	8.29% · $135M	43.59% · $710M	32.72% · $533M	0.25% · $4M	100% · $1,629M
FY 2016 Q4	6.86% · $353M	1.57% · $81M	12.83% · $660M	10.32% · $531M	68.42% · $3,520M	100% · $5,145M
FY 2017 Q1	12.13% · $330M	0.44% · $12M	64.79% · $1,763M	22.01% · $599M	0.62% · $17M	100% · $2,721M
FY 2017 Q2	7.83% · $268M	37.83% · $1,294M	30.14% · $1,031M	17.33% · $593M	6.87% · $235M	100% · $3,421M
FY 2017 Q3	19.61% · $326M	1.32% · $22M	37% · $615M	35.5% · $590M	6.56% · $109M	100% · $1,662M
FY 2017 Q4	21.14% · $330M	Unavailable	8.65% · $135M	38.05% · $594M	32.16% · $502M	100% · $1,561M
FY 2018 Q1	12.97% · $278M	0% · $0M	57.51% · $1,233M	29.15% · $625M	0.37% · $8M	100% · $2,144M
FY 2018 Q2	4.28% · $246M	1.32% · $76M	11.39% · $655M	10.81% · $622M	72.2% · $4,153M	100% · $5,752M
FY 2018 Q3	25.4% · $252M	3.53% · $35M	7.66% · $76M	62.8% · $623M	0.6% · $6M	100% · $992M
FY 2018 Q4	6.71% · $292M	0.6% · $26M	4.76% · $207M	14.34% · $624M	73.6% · $3,203M	100% · $4,352M
FY 2019 Q1	15.25% · $291M	5.45% · $104M	43.19% · $824M	35.48% · $677M	0.63% · $12M	100% · $1,908M
FY 2019 Q2	9.7% · $206M	0.71% · $15M	57.61% · $1,223M	31.75% · $674M	0.24% · $5M	100% · $2,123M
FY 2019 Q3	9.55% · $302M	47.31% · $1,496M	21.54% · $681M	21.22% · $671M	0.38% · $12M	100% · $3,162M
FY 2019 Q4	3.61% · $335M	2.28% · $212M	1.6% · $149M	7.23% · $671M	85.28% · $7,919M	100% · $9,286M
FY 2020 Q1	4.6% · $301M	2.22% · $145M	5.09% · $333M	11.07% · $724M	77.01% · $5,035M	100% · $6,538M
FY 2020 Q2	12.58% · $283M	2.49% · $56M	27.96% · $629M	32.13% · $723M	24.84% · $559M	100% · $2,250M
FY 2020 Q3	23% · $293M	Unavailable	19.31% · $246M	56.75% · $723M	0.94% · $12M	100% · $1,274M
FY 2020 Q4	17.05% · $336M	14.66% · $289M	5.99% · $118M	36.73% · $724M	25.57% · $504M	100% · $1,971M
FY 2021 Q1	29.74% · $334M	0% · $0M	0% · $0M	69.28% · $778M	0.98% · $11M	100% · $1,123M
FY 2021 Q2	3.59% · $281M	4.73% · $370M	0.87% · $68M	9.97% · $780M	80.84% · $6,325M	100% · $7,824M
FY 2021 Q3	19.37% · $363M	32.34% · $606M	0.48% · $9M	41.68% · $781M	6.14% · $115M	100% · $1,874M
FY 2021 Q4	14.14% · $377M	0.67% · $18M	21.56% · $575M	29.28% · $781M	34.35% · $916M	100% · $2,667M
FY 2022 Q1	24.55% · $378M	0% · $0M	20.45% · $315M	54.94% · $846M	0.06% · $1M	100% · $1,540M
FY 2022 Q2	16.54% · $271M	5.56% · $91M	26.19% · $429M	51.71% · $847M	0% · $0M	100% · $1,638M
FY 2022 Q3	21.01% · $330M	0% · $0M	25.08% · $394M	53.91% · $847M	0% · $0M	100% · $1,571M
FY 2022 Q4	14.75% · $389M	0% · $0M	53.3% · $1,406M	31.96% · $843M	0% · $0M	100% · $2,638M
FY 2023 Q1	8.24% · $426M	23.05% · $1,191M	6.5% · $336M	17.48% · $903M	44.73% · $2,311M	100% · $5,167M
FY 2023 Q2	15.8% · $323M	33.07% · $676M	6.9% · $141M	44.23% · $904M	0% · $0M	100% · $2,044M
FY 2023 Q3	15.97% · $332M	0% · $0M	3.42% · $71M	43.48% · $904M	37.13% · $772M	100% · $2,079M
FY 2023 Q4	8.77% · $378M	0% · $0M	2.25% · $97M	21% · $905M	67.97% · $2,929M	100% · $4,309M
FY 2024 Q1	24.86% · $354M	0% · $0M	10.67% · $152M	64.47% · $918M	0% · $0M	100% · $1,424M
FY 2024 Q2	28.33% · $461M	1.35% · $22M	13.89% · $226M	56.42% · $918M	0% · $0M	100% · $1,627M
FY 2024 Q3	23.91% · $346M	3.59% · $52M	9.12% · $132M	63.37% · $917M	0% · $0M	100% · $1,447M
FY 2024 Q4	13.72% · $426M	4.41% · $137M	52.45% · $1,628M	29.41% · $913M	0% · $0M	100% · $3,104M
FY 2025 Q1	13.3% · $520M	Unavailable	63.73% · $2,492M	22.97% · $898M	0% · $0M	100% · $3,910M
FY 2025 Q2	25.42% · $404M	Unavailable	18.12% · $288M	56.45% · $897M	0% · $0M	100% · $1,589M
FY 2025 Q3	28.81% · $476M	5.93% · $98M	10.96% · $181M	54.3% · $897M	0% · $0M	100% · $1,652M
FY 2025 Q4	28.16% · $459M	0% · $0M	16.81% · $274M	55.03% · $897M	0% · $0M	100% · $1,630M
FY 2026 Q1	18.67% · $504M	0% · $0M	4.56% · $123M	33.72% · $910M	43.05% · $1,162M	100% · $2,699M
FY 2026 Q2	13.3% · $468M	Unavailable	10.57% · $372M	25.87% · $910M	50.26% · $1,768M	100% · $3,518M
FY 2026 Q3	30.41% · $444M	Unavailable	7.19% · $105M	62.4% · $911M	0% · $0M	100% · $1,460M
FY 2026 Q4	21.81% · $488M	18.15% · $406M	19.45% · $435M	40.59% · $908M	0% · $0M	100% · $2,237M
FY 2027 Q1	17.63% · $503M	40.73% · $1,162M	9.36% · $267M	32.28% · $921M	0% · $0M	100% · $2,853M

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Medtronic plc.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue: Reported revenue from company filings.
Free cash flow: Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin: Reported net income / revenue × 100.
P/E: Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC: NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation: Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.

Reported revenue and sources

Medtronic plc financials